a clinical-stage biotechnology company, which engages in the discovery and development of engineered T cell therapies for B cell-mediated autoimmune diseases
Industry Biotechnology
A.I.dvisor indicates that over the last year, CABA has been loosely correlated with PLRX. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if CABA jumps, then PLRX could also see price increases.
Ticker / NAME | Correlation To CABA | 1D Price Change % | ||
---|---|---|---|---|
CABA | 100% | -5.74% | ||
PLRX - CABA | 39% Loosely correlated | -6.68% | ||
AUTL - CABA | 37% Loosely correlated | -8.51% | ||
ALLO - CABA | 36% Loosely correlated | -9.56% | ||
ENTO - CABA | 36% Loosely correlated | -17.24% | ||
RCKT - CABA | 36% Loosely correlated | -5.42% | ||
More |